Terms: = Lymphoma AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
73 results:
1. NLRC5-ciita Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity.
Santharam MA; Shukla A; Levesque D; Kufer TA; Boisvert FM; Ramanathan S; Ilangumaran S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108368
[TBL] [Abstract] [Full Text] [Related]
2. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.
Gebremariam GT; Fentie AM; Beyene K; Sander B; Gebretekle GB
BMC Health Serv Res; 2022 Dec; 22(1):1600. PubMed ID: 36585648
[TBL] [Abstract] [Full Text] [Related]
4. MYC/BCL2 double- and MYC/BCL2/BCL6 triple-hit follicular lymphomas associated with t(8;14;18)(q24;q32;q21).
Takeoka K; Maekawa F; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Sumiyoshi S; Ohno H
J Clin Exp Hematop; 2022; 62(4):258-267. PubMed ID: 36575003
[TBL] [Abstract] [Full Text] [Related]
5. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
[TBL] [Abstract] [Full Text] [Related]
6. Osteocyte ciita aggravates osteolytic bone lesions in myeloma.
Liu H; He J; Bagheri-Yarmand R; Li Z; Liu R; Wang Z; Bach DH; Huang YH; Lin P; Guise TA; Gagel RF; Yang J
Nat Commun; 2022 Jun; 13(1):3684. PubMed ID: 35760800
[TBL] [Abstract] [Full Text] [Related]
7. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
Guo B; Huang Y; Duan Y; Liao C; Cen H
Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
[TBL] [Abstract] [Full Text] [Related]
8. HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.
Forlani G; Shallak M; Accolla RS; Romanelli MG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360767
[TBL] [Abstract] [Full Text] [Related]
9. Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Frontzek F; Ziepert M; Nickelsen M; Altmann B; Glass B; Haenel M; Truemper L; Held G; Bentz M; Borchmann P; Dreyling M; Viardot A; Kroschinsky FP; Metzner B; Staiger AM; Horn H; Ott G; Rosenwald A; Loeffler M; Lenz G; Schmitz N
Lancet Haematol; 2021 Apr; 8(4):e267-e277. PubMed ID: 33667420
[TBL] [Abstract] [Full Text] [Related]
10. Immunogenomic Landscape of Hematological Malignancies.
Dufva O; Pölönen P; Brück O; Keränen MAI; Klievink J; Mehtonen J; Huuhtanen J; Kumar A; Malani D; Siitonen S; Kankainen M; Ghimire B; Lahtela J; Mattila P; Vähä-Koskela M; Wennerberg K; Granberg K; Leivonen SK; Meriranta L; Heckman C; Leppä S; Nykter M; Lohi O; Heinäniemi M; Mustjoki S
Cancer Cell; 2020 Sep; 38(3):380-399.e13. PubMed ID: 32649887
[TBL] [Abstract] [Full Text] [Related]
11. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
[TBL] [Abstract] [Full Text] [Related]
12. Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression.
Jiang XN; Yu BH; Yan WH; Lee J; Zhou XY; Li XQ
Oncoimmunology; 2020; 9(1):1683346. PubMed ID: 32002294
[No Abstract] [Full Text] [Related]
13. Restriction factors in human retrovirus infections and the unprecedented case of ciita as link of intrinsic and adaptive immunity against HTLV-1.
Forlani G; Shallak M; Ramia E; Tedeschi A; Accolla RS
Retrovirology; 2019 Nov; 16(1):34. PubMed ID: 31783769
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
Xie M; Huang X; Ye X; Qian W
Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
[TBL] [Abstract] [Full Text] [Related]
15. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Mottok A; Hung SS; Chavez EA; Woolcock B; Telenius A; Chong LC; Meissner B; Nakamura H; Rushton C; Viganò E; Sarkozy C; Gascoyne RD; Connors JM; Ben-Neriah S; Mungall A; Marra MA; Siebert R; Scott DW; Savage KJ; Steidl C
Blood; 2019 Sep; 134(10):802-813. PubMed ID: 31292115
[TBL] [Abstract] [Full Text] [Related]
16. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Bromberg JEC; Issa S; Bakunina K; Minnema MC; Seute T; Durian M; Cull G; Schouten HC; Stevens WBC; Zijlstra JM; Baars JW; Nijland M; Mason KD; Beeker A; van den Bent MJ; Beijert M; Gonzales M; de Jong D; Doorduijn JK
Lancet Oncol; 2019 Feb; 20(2):216-228. PubMed ID: 30630772
[TBL] [Abstract] [Full Text] [Related]
17. Gray-zone lymphoma Between cHL and Large B-Cell lymphoma: A Histopathologic Series From the LYSA.
Sarkozy C; Copie-Bergman C; Damotte D; Ben-Neriah S; Burroni B; Cornillon J; Lemal R; Golfier C; Fabiani B; Chassagne-Clément C; Parrens M; Herbaux C; Xerri L; Bossard C; Laurent C; Cheminant M; Cartron G; Cabecadas J; Molina T; Salles G; Steidl C; Ghesquières H; Mottok A; Traverse-Glehen A
Am J Surg Pathol; 2019 Mar; 43(3):341-351. PubMed ID: 30540571
[TBL] [Abstract] [Full Text] [Related]
18. Cyclin D1-positive Mediastinal Large B-Cell lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
Chen BJ; Ruminy P; Roth CG; Bisig B; Mankel B; Steinhilber J; Bohers E; Jardin F; Fend F; Swerdlow SH; Copie-Bergman C; de Leval L; Quintanilla-Martinez L
Am J Surg Pathol; 2019 Jan; 43(1):110-120. PubMed ID: 30211726
[TBL] [Abstract] [Full Text] [Related]
19. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract] [Full Text] [Related]
20. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract] [Full Text] [Related]
[Next]